SC 13D/A

NEW ENTERPRISE ASSOCIATES 15, L.P. / ONKURE THERAPEUTICS, INC. -- SCHEDULE 13D/A

Company: OnKure Therapeutics, Inc.
Filed: October 8, 2024
Accession Number: 0001072613-24-000769

View Document ↗ View on SEC.gov ↗